Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

AJ Products and Avensia Launch B2B E-Commerce Site of the Future

During the past 45 years AJ Products have delivered interior design products to offices, schools, warehouses, and industries. The company, that built their longstanding success on mail-orders, now launches a new e-commerce site where the customer buying experience is front and center.AJ Products  operates on 19 markets across Europe. The launch of the new e-commerce  site is fundamental to the company’s strategy to increase international presence and market share. The goal is to deliver a fast,

Saab’s Digital Towers Selected for Belgium

Saab Digital Air Traffic Solutions (SDATS) has been selected for a long-term framework agreement by skeyes, the Air Traffic Control organisation of Belgium, for their Digital Tower programme.The agreement calls for a phased introduction of Digital Towers for up to six airports and three centres in Belgium. The framework agreement has a fixed part and a conditional part for a total value of just over 48 million Euro, spread over 18 years. The first phase will cover the airports of Liege and Charleroi and a centre in Namur. Delivery to skeyes will start in 2022, with initial operations to be

SWESTR can be used as the reference rate for financial contracts from 2 September

As of 2 September 2021, the Riksbank's transaction-based reference rate, SWESTR, can be used in financial contracts. The test period for SWESTR has thus ended. On Thursday 2 September at 11.00, a digital press conference will be held with Deputy Governor Martin Flodén on why the Riksbank advocates the use of SWESTR.On Thursday 2 September at 11.00, the Riksbank will publish the first official value for the transaction-based reference rate, SWESTR. This means that financial markets can now start using SWESTR as the reference rate in financial contracts. SWESTR is based entirely on reported

Getinge UKI appoints Amy Rothwell as General Manager Healthcare Sales

Amy Rothwell has been appointed General Manager Healthcare Sales for Getinge UKI starting August 31, 2021.Getinge UK and Ireland are excited to announce that Amy Rothwell has decided to join the organisation as General Manager Healthcare Sales. Amy has extensive senior sales management experience and has spent the past 11 years with Bausch + Lomb as Business Unit Director for UKI and Nordics. “Amy’s result orientation, analytical and strategic skills as well as the ability to hire and develop talent will be invaluable to our organisation moving forward securing business sustainability

Changes to Probi’s Nomination Committee

At the 2021 Annual General Meeting of Probi AB, the Probi Nomination Committee ahead of the Annual General Meeting 2022 was appointed. The Fourth Swedish National Pension Fund has informed that Marianne Flink will replace Jannis Kitsakis as a member of the Nomination Committee, representing the Fourth Swedish National Pension Fund. The Nomination Committee ahead of the Annual General Meeting 2022 will henceforth consist of Heinz-Jürgen Bertram (representing Symrise), Monica Åsmyr (representing Swedbank Robur funds), Marianne Flink (representing the Fourth Swedish National Pension Fund)

Increased number of shares and votes in Vitec

The number of shares and votes in Vitec Software Group AB (publ) has increased as a result of the directed issue of 2,000,000 shares of series B that the company carried out August 25, 2021.As of today, the total number of registered and outstanding shares is 35,033,902, divided on 3,050,000 shares of series A and 31,983,902 shares of series B. The number of votes has increased with 2,000,000 from 60,483,902 to 62,483,902. The share capital has increased from SEK 3,303,390.20 to SEK 3,503,390.20.   For more information, please contact Patrik Fransson, Investor Relations, Vitec

Notice to attend the Extraordinary General Meeting in Rottneros AB (publ)

The shareholders in Rottneros AB (publ), reg. no. 556013-5872, (“Rottneros”) with its registered office in Sunne, are hereby invited to the Extraordinary General Meeting (the “EGM”) on Wednesday 22 September 2021. INFORMATION RELATED TO COVID-19 Rottneros is mindful of the health and well-being of its shareholders and employees. It is important for Rottneros to take social responsibility and contribute to reduce the risk of transmissions of Covid‑19.  As regard to the extraordinary situation, the EGM will be carried out only through advance voting (postal voting) pursuant to temporary

Tele2 appoints Torkel Sigurd as EVP Corporate Affairs

Stockholm –Tele2 AB (“Tele2”) (Nasdaq Stockholm: TEL2 A and TEL2 B) appoints of Torkel Sigurd as new Executive Vice President Corporate Affairs and member of the Group Leadership Team.Torkel Sigurd has 20 years of experience within telecom and has been part of the Tele2 family for 14 years. Most notably, Torkel has led Tele2’s M&A unit during the company’s international consolidation the last few years. He also has experience from leading a number of commercial and product related functions. Torkel assumes the role of Executive Vice President Corporate Affairs starting 1 September 2021

Dentalum Operations AB (publ) publishes Q2 Interim Report

Dentalum has continued to deliver on its growth strategy through the acquisitions of three additional clinics during the second quarter. Dentalum further strengthened its presence in the Stockholm region through the acquisitions of Solna Dental and Arenatandläkarna, with combined annual revenues of SEK 32 million and 22 employees. Dentalum also expanded into Kalmar region through the acquisition of Tareqs Klinik with annual revenues of SEK 15 million and five employees. During the second quarter, Dentalum’s clinics have seen a general recovery in patient inflow and revenues, as the roll-

Stora Enso completes the union negotiations in Kvarnsveden

STORA ENSO OYJ INVESTOR NEWS 31 August 2021 at 10.00 EESTStora Enso has completed the union negotiations regarding the closure of pulp and paper production at Kvarnsveden. A total of 340 people will be permanently laid off. Some 25% of the redundancies can be managed through pension arrangements, and 100 people have already found new jobs within Stora Enso or with an external employer. The redundancies will mostly take effect in November. In April 2021, Stora Enso announced a plan to permanently close down pulp and paper production at its Kvarnsveden site due to the declining paper

SRV will build the Woodspin fibre mill in Eteläportti, Jyväskylä

SRV GROUP PLC     INVESTOR NEWS      2021 31 AUGUST    10:00 EET SRV will build the Woodspin fibre mill in Eteläportti, Jyväskylä SRV and Jykia, a municipally-owned property development company, have signed a contract agreement on the implementation of a fibre mill in Eteläportti, Jyväskylä. The project is valued at a total of about EUR 50 million, of which the project management contract accounts for around EUR 16 million. The project will be recognised in SRV’s order backlog for August. Construction work will begin in autumn 2021. The factory facilities will be completed at the end

Grant of warrants

MapsPeople A/S | Grant of warrants   MAY NOT BE PUBLISHED, DISTRIBUTED, OR SUPPLIED OR IN PARTICULAR, DIRECTLY OR INDIRECTLY, IN OR TO THE USA, AUSTRALIA, CANADA, OR JAPAN. This announcement does not constitute an offering circular, Prospectus, or other offer document. No one should purchase or subscribe for any securities in MapsPeople A/S ("MapsPeople" or the "Company") except on the basis of information in the Prospectus published by the Company in connection with the Offering and admission of such securities to trading on Nasdaq First North Premier Growth Market Denmark ("First

MapsIndoors delivers growth of 64% resulting in a total ARR growth of 42% for the company

MapsPeople A/S | Half-year report 2021-H1  MAY NOT BE PUBLISHED, DISTRIBUTED, OR SUPPLIED OR IN PARTICULAR, DIRECTLY OR INDIRECTLY, IN OR TO THE USA, AUSTRALIA, CANADA, OR JAPAN. This announcement does not constitute an offering circular, Prospectus, or other offer document. No one should purchase or subscribe for any securities in MapsPeople A/S ("MapsPeople" or the "Company") except on the basis of information in the Prospectus published by the Company in connection with the Offering and admission of such securities to trading on Nasdaq First North Premier Growth Market Denmark ("

Impero reports 44% growth in Annual Recurring Revenue for 2021-H1 compared to 2020-H1 in line with IPO strategy plan

Interim financial report for the period January 1, 2021 to June 30, 2021 Highlights from 2021-H1 · Impero increased ARR by 44% in 2021-H1 compared to 2020-H1. ARR for 2021-H1 amounted to DKK 14.2M on June 30, 2021. Impero’s growth is in line with the strategy plan presented in the IPO document. · Impero successfully maintained an uplift of 8% from existing customers. · Impero presented churn below 2%. Impero maintains expectations for Annual Recurring Revenue for the entire year of 2021, expecting ARR at the level of DKK 18-19.5M, as announced in the IPO document.

BioStock: Elicera Therapeutics comes out of the gate running in Q2

For Swedish immuno-oncology company Elicera Therapeutics, the highlight of Q2 was going public and being listed on Nasdaq First North Growth Market, all while raking in more than 60 MSEK in a share issue. The events came as the company had reached new heights with its development pipeline and technology platform, iTANK.Read the article at biostock.se: https://www.biostock.se/en/2021/08/elicera-therapeutics-comes-out-of-the-gate-running-in-q2/ This is a press release from BioStock - Connecting Innovation & Capital.https://www.biostock.se

Medivir receives regulatory approval from MHRA for phase 1/2a combination study with MIV-818

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announced that the company has received regulatory approval from the British Medicines & Healthcare products Regulatory Agency (MHRA) for its upcoming phase 1/2a combination study with the company's leading candidate drug MIV-818 against liver cancer. In the study, MIV-818 will be administered in two combinations, either with lenvatinib, a tyrosine kinase inhibitor or pembrolizumab, an anti-PD-1 check-point inhibitor. The planned trial will be an open-label, multi-center phase 1/2a study starting with a dose escalation part to

Atlas Copco has acquired a German company specialized in positioning technology

Nacka, Sweden, August 31, 2021: Atlas Copco has acquired the assets of NATEV GmbH. The company was founded in 2010 and specializes in position solutions for assembly tools used in industrial production.NATEV has ten employees and is located in Borken, in north-western Germany. In 2019, the company’s sales amounted to approximately 1 MEUR (10.4 MSEK) and in 2020 approximately MEUR 0.5 (MSEK 5.2) NATEV develops systems for real-time positioning and imaging solutions in close cooperation with key customers in the automotive industry. Products include hardware and software used to monitor

Interim report January – June 2021

The period in summary First half year January 1 – June 30, 2021 · On June 17th the Committee for Medicinal Products for Veterinary Use (CVMP) at the European Medicines Agency (EMA) adopted a positive opinion, recommending approval of Strangvac within the EU. · On April 12th Intervacc announced an exclusive distribution agreement with Dechra Pharmaceuticals PLC, to commercialize Intervacc’s leading vaccine candidate Strangvac in Europe, excluding the Nordic and Baltic countries where Intervacc will market and sell Strangvac directly. · The study "Globetrotting strangles: the

Biosergen publishes interim report for the second quarter 2021

Tuesday, August 31, 2021: Biosergen AB (“Biosergen” or the “Company”) thereby publishes the interim report for the second quarter 2021. The interim report is available as an attached document and on the company website (www.biosergen.net)Biosergen AB was registered in February 2021. On April 16, 2021, the company acquired Biosergen AS with the subsidiary Select Pharma PTY LTD and formed the group with Biosergen AB as parent company. As the company is new there are no comparative figures. Summary of the Interim Report for Q2 2021 Consolidated group evenue

Change in number of shares and votes in Evolution AB (publ)

During August, warrants of series 2018/2021 have been exercised to subscribe for 5,735 shares in Evolution AB (publ). As of 31 August 2021, following the exercise of warrants set out above, the number of shares and votes in Evolution AB (publ) amounts to 215,111,115.   For further information, please contact: Jacob Kaplan, CFO, ir@evolution.com.   This information is such that Evolution AB (publ) is obliged to publish according to the Swedish Financial Instruments Trading Act. This press release was submitted for publication by the person above on 31 August 2021 at 08:30

Interim Financial Report – Half year of 2021 (H1 2021)

SGL International A/S (SGL Group – formerly SGL TransGroup International A/S) has today published its Interim Financial Report for the first half year of 2021 (H1 2021). SGL Group (SGL International A/S) · For SGL Group, the H1 2021 revenue was DKK 3,757m versus DKK 2,511m in H1 2020; corresponding to growth of 50% driven by an overall increase of activities for Air and Ocean in Nordics and Asia Pacific and an increase in freight rates globally. · The total Gross Profit was DKK 539m; equivalent to a Gross Margin of 14.4%. · The H1 2021 EBITDA before special items and excluding

Cary Group reports strong growth and further acquisitions during the second quarter

Cary Group, a leading European vehicle glass repair and replacement service provider, today presents selected information on the company's financial and operational development for the second quarter of 2021.Anders Jensen, CEO of Cary Group, comments:”In the second quarter, demand picked up again in our key markets, following an easing of Covid-19 related lock-down measures, and Cary Group was able to deliver strong growth of 40%. Our M&A journey continued with the acquisition of Quick Car Fix in Norway, specialising in SMART repair (Small to Medium Area Repair Techniques). In total, we

WindowMaster realized record high growth in orders and sales in 2021-H1

Company Announcement No. 16-2021 – Inside Information Copenhagen, August 31, 2021Highlights from 2021-H1 WindowMaster realized strong sales growth in the 1[st] half of 2021 – with high activity in all markets – despite continued COVID-19 constraints, Brexit etc. Both order intake and turnover reached an all-time high. · Net sales for 2021-H1 ended at 107m DKK including the acquisition of Climatic A/S representing a 21.7% increase compared to 2020-1H. Under this positive development lies further – not yet accounted for – postponed turnover of 2m DKK caused by supply chain delays

Eurocine Vaccines discloses year-end report for the fiscal year 2020/2021

Eurocine Vaccines AB (“Eurocine Vaccines”) hereby discloses the year-end report for the fiscal year 2020/2021. Below is a summary of the report. The full report is available on Eurocine Vaccines’ website and as an attachment. 2021-04-01– 2021-06-30 (fourth quarter) · Profit after tax for the quarter amounted to -6.0 MSEK (-2.5 MSEK) · Income for the quarter amounted to 2 KSEK (0 KSEK) · Earnings per share for the quarter amounted to SEK -0.768 (SEK -0.479) * 2020-07-01– 2021-06-30 (fiscal year, twelve months) · Profit after tax for

There are no items matching the current filter
There are no more items matching the current filter
Back to top